About
Contact & Profiles
A5013663507
Research Areas
- CAR-T cell therapy research
- RNA Interference and Gene Delivery
- Virus-based gene therapy research
University of Leeds
2019
Abstract Background Brain metastases (BrM) develop in 20–40% of cancer patients and represent an unmet clinical need. Limited access drugs into the brain because blood-brain barrier is at least partially responsible for therapeutic failure, necessitating improved drug delivery systems. Methods Green fluorescent protein (GFP)-transduced murine nontransduced human hematopoietic stem cells (HSCs) were administered mice (n = 10 3). The HSC progeny mouse BrM patient-derived tissue 6) was...
10.1093/jnci/djz181
article
EN
cc-by
JNCI Journal of the National Cancer Institute
2019-09-06
Coming Soon ...